Medicines UK is the trade body for manufacturers of off-patent generic and biosimilar medicines which fulfil four out of five NHS prescriptions. In our podcast we speak to our industry, Government partners, NHS colleagues and stakeholders about the key issues for our sector highlighting challenges and opportunities.
…
continue reading
Jeremydurrant Podcasts
1
Medicine Matters - Episode 4 Lily Smart speaks to Harry McQuillan
20:03
20:03
Play later
Play later
Lists
Like
Liked
20:03
Lily Smart, Head of Commercial Intiatives at Sandoz, a Medicines UK member company, speaks to Harry McQuillan, chair of Numark and former chief executive of Community Pharmacy Scotland on the changing landscape in pharmacy, how to make a success of the NHS 10-year plan and the future trends within the sector.…
…
continue reading
1
Medicine Matters - Episode 3 - Loss of Exclusivity data
15:17
15:17
Play later
Play later
Lists
Like
Liked
15:17
In this latest episode of the Medicine Matters podcast brought to you by Medicines UK, we explore loss of exclusivity data and why its important to the NHS. Jeremy Durrant, director of communications and external engagement at Medicines UK talks to his colleague Robert Russell-Pavier, Director of Economics and Public Affairs on forthcoming patent e…
…
continue reading
1
Medicine Matters - International Women's Day
17:32
17:32
Play later
Play later
Lists
Like
Liked
17:32
In the second episode of the British Generic Manufacturers Association's podcast series, chair Diane DiGangi-Trench speaks to Clara Carter, who is heading up the BGMA's new women's network.By BGMA
…
continue reading
1
The role of medicines in driving growth with Rosalind Campion, Director of the Office for Life Sciences
20:27
20:27
Play later
Play later
Lists
Like
Liked
20:27
The BGMA is the trade body for manufacturers of off-patent generic and biosimilar medicines which fulfil four out of five NHS prescriptions. In our podcast we speak to Government partners and stakeholders about the key issues for our sector highlighting challenges and opportunities.By jeremydurrant
…
continue reading
